torl-1-23
torl biotherapeutics
['torl,1,23']
#asco23 dr. gottfried konecny shares initial results from the first-in-human study that evaluated the safety and tolerability of torl-1-23 in patients with advanced cancer. 
We are accelerating discoveries to prevent and cure cancer.